Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2013


9th Public Relations & Communications Summit

16 Jul 2013 - 17 Jul 2013 - Boston, MA, USA



Bookmark and Share


Out of the Box Keynotes. New Location. Un-conference discussion intensive sessions. The Senior Leadership Forum. Patient perspectives.

What Can You Expect from the 9th PR & Communications Summit?

The Senior Leadership Forum: A dedicated forum for senior directors or higher to discuss outside-of-communications topics in a 100% discussion-based format.

New Perspectives: We did extensive research and found the highest caliber of professionals working on key projects now to share their invaluable insights.

New Location: Boston, in addition to its growing pharma heavy presence, provides new faces and a new city to use as the backdrop to the event, which includes a tour of the MIT research facility.

Customizable Networking and Down Time: Whether meditation is your bag or speed networking and a tour of a research facility is what you want, you have options at this year’s event to maximize your time and monetary investment to your specifications.

Brand New Topics: Patient perspectives, Healthcare Reform interview, Innovation in Healthcare discussions- on top of the PR and communications discussions you need, we’re including more healthcare related topics to help you do your job better.



Further information
Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!